HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dow Wolff Cellulosics

This article was originally published in The Rose Sheet

Executive Summary

Dow Chemical Company creates Dow Wolff Cellulosics, a $1 bil. specialty business unit that sells high-performance cellulosics for personal care and other applications, firm announces July 2. The new business unit combines all activities and interests of two previously established companies - Wolff Walsrode AG and Dow Chemical's Water Soluble Polymers business. The new unit sells cellulosics such as SoftCAT SX Polymers, which figure in hair care, Methocel cellulose ethers, which are used in skin care, and Polyox water-soluble resins, which are an important component of skin cleansers, oral care, hair care and shaving products. The new unit will be led by Martin Sonntag as general manager. Steve Swartzmiller will serve as director of global innovation and R&D, Reiner Roghmann as global manufacturing director, and Volker Eckhardt as head of the firm's methyl cellulosics business manufacturing, firm says...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014830

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel